RadNet, Inc. Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent
RadNet, Inc. (RDNT) reported Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent of -$65.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent · last filed 2022-03-01
- RadNet, Inc. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, portion attributable to parent for the quarter ending 2021-03-31 was -$12.00K, a 1300.00% decline year-over-year.
- RadNet, Inc. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, portion attributable to parent for the quarter ending 2020-12-31 was -$107.00K.
- RadNet, Inc. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, portion attributable to parent for the quarter ending 2020-09-30 was $11.00K.
- RadNet, Inc. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, portion attributable to parent for the quarter ending 2020-06-30 was -$7.00K, a 333.33% decline year-over-year.
- RadNet, Inc. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, portion attributable to parent for fiscal 2021 was -$65.00K.
- RadNet, Inc. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, portion attributable to parent for fiscal 2020 was -$101.00K.
- RadNet, Inc. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, portion attributable to parent for fiscal 2019 was -$32.00K.
- RadNet, Inc. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, portion attributable to parent for fiscal 2018 was -$69.00K, a 365.38% decline from fiscal 2017.
| Period end | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$65.00K 10-K · filed 2022-03-01 | |||
| 2021-03-31 | -$12.00K 10-Q · filed 2021-05-10 | -$119.00K derived: sum of 2 quarters · filed 2022-03-01 | -$108.00K derived: sum of 3 quarters · filed 2022-03-01 | -$115.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-12-31 | -$107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$96.00K derived: sum of 2 quarters · filed 2022-03-01 | -$103.00K derived: sum of 3 quarters · filed 2022-03-01 | -$101.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $11.00K 10-Q · filed 2020-11-09 | $4.00K derived: sum of 2 quarters · filed 2020-11-09 | $6.00K 10-Q · filed 2020-11-09 | $1.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$7.00K 10-Q · filed 2020-08-10 | -$6.00K 10-Q · filed 2020-08-10 | -$10.00K derived: sum of 3 quarters · filed 2022-03-01 | -$33.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $1.00K 10-Q · filed 2021-05-10 | -$3.00K derived: sum of 2 quarters · filed 2022-03-01 | -$26.00K derived: sum of 3 quarters · filed 2022-03-01 | -$23.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$27.00K derived: sum of 2 quarters · filed 2022-03-01 | -$24.00K derived: sum of 3 quarters · filed 2022-03-01 | -$32.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | -$23.00K 10-Q · filed 2020-11-09 | -$20.00K derived: sum of 2 quarters · filed 2020-11-09 | -$28.00K 10-Q · filed 2020-11-09 | -$32.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-06-30 | $3.00K 10-Q · filed 2020-08-10 | -$5.00K 10-Q · filed 2020-08-10 | -$9.00K derived: sum of 3 quarters · filed 2021-03-16 | -$5.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-03-31 | -$8.00K 10-Q · filed 2020-05-11 | -$12.00K derived: sum of 2 quarters · filed 2021-03-16 | -$8.00K derived: sum of 3 quarters · filed 2021-03-16 | -$99.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2018-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $0.00 derived: sum of 2 quarters · filed 2021-03-16 | -$91.00K derived: sum of 3 quarters · filed 2021-03-16 | -$69.00K 10-K · filed 2021-03-16 |
| 2018-09-30 | $4.00K 10-Q · filed 2019-11-12 | -$87.00K derived: sum of 2 quarters · filed 2019-11-12 | -$65.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$91.00K 10-Q · filed 2019-08-09 | -$69.00K 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $22.00K 10-Q · filed 2019-05-10 | |||
| 2017-12-31 | $26.00K 10-K · filed 2020-03-16 | |||
| 2016-12-31 | -$49.00K 10-K · filed 2019-03-18 | |||
| 2015-12-31 | -$41.00K 10-K · filed 2018-03-19 | |||
| 2014-12-31 | -$62.00K 10-K · filed 2017-03-17 | |||
| 2013-12-31 | -$89.00K 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |